BioCina
Anthony Morgan is a seasoned professional in the biotechnology field with extensive experience in operations and project management. Currently serving as the Director of Operations at BioCina since October 2021, Anthony oversees the development and manufacturing of recombinant biotherapeutics. Prior roles include significant positions at Pfizer from November 2013 to September 2021, where responsibilities encompassed Production Lead, Business Development Manager, and Project Manager. Earlier experience at Thermo Fisher Scientific included various roles from Technical Manufacturing Technician to General Manager. Anthony holds a Post Graduate Diploma in Science (Biochemistry) from the University of Canterbury, a Certificate IV in Project Management Practice from the Australian Institute of Management South Australia, and a Bachelor of Science (Plant and Microbial Sciences) from the University of Canterbury.
This person is not in any teams
BioCina
BioCina is a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), offering highest-quality, cost-effective cell line, process, analytical and formulation development, and cGMP clinical & commercial manufacturing for the microbial, pDNA and mRNA modalities. BioCina’s first facility in Adelaide, South Australia is a testament to the quality of its work. It has a rich history of developing and manufacturing both clinical and commercial drug substance, backed by most critical SME’s having an average tenure of 15+ years at the site. BioCina boasts an elite quality record having successfully passed regulatory inspections by the US FDA, EMA and Health Canada. It is licensed by the Australian TGA for cGMP manufacturing of bulk drug substance or active intermediates. Through a partnership with NovaCina, BioCina offers clients a highest-quality fill-and-finish solution. BioCina is proud to have clients globally, including U.S., Europe, and the Asia Pacific. Because BioCina is not a drug developer, it only serves clients' products. As one of the fastest growing companies in the biopharmaceutical industry across Australia, BioCina was awarded the 2024 South Australia “Emerging Business of the Year” award. Learn more at https://biocina.com.